Vaccines & Immunology

mRNA platforms, boosters, monoclonals, and immune‑system science.

  • 18 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Vaccines & Immunology


nature.com > articles > s41586-026-11176-1

Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism

13+ hour, 21+ min ago   (1015+ words) Nature (2026) Cite this article By contrast, both TYK2 inhibitor and CRISPR knockout diminished IL-10-induced STAT3 phosphorylation in CD8+ T cells (Fig. 1e,f and Extended Data Figs. 1g and 2d) and completely abolished augmentation of granzyme B and IFNγ production (Fig. 1g,h), indicating a strict dependence…...


stocktitan.net > news > IMMP > immutep-and-monash-university-secure-further-arc-linkage-projects-zu5x8xfc8rwq.html

Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research

5+ hour, 21+ min ago   (373+ words) The project will use structural biology, cellular immunology and advanced imaging to investigate immune regulation. The research builds on the collaboration’s human LAG-3/MHC Class II crystal structure published in December 2024. Immutep will contribute financially to the study. Neither the…...


miragenews.com > iit-develops-switchable-immunotherapy-strategy-1760245

IIT Develops Switchable Immunotherapy Strategy Against Cancer

3+ hour, 22+ min ago   (555+ words) Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. Naples (Italy), 14th October 2026 – A genetic switch that activates immune cells as they fight tumours: this…...


macaubusiness.com > adagene-to-participate-in-h-c-wainwright-4th-annual-immune-cell-engager-virtual-conference

Adagene to Participate in H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference

1+ hour, 21+ min ago   (72+ words) H.C. Wainwright 4th Annual Immune Cell Engager Virtual ConferenceFormat: Fireside chatDate: October 15, 2026Time: 1:30 – 2:00 p.m. ET SAFEbody® is a registered trademark in the United States, China, Australia, Japan, Singapore, and the European Union. SINGAPORE and MUNICH, Oct. 14, 2026 (GLOBE NEWSWIRE) — Nibe Following Clean Core Thorium…...


southfloridahospitalnews.com > 10/14/2026 > ai-tool-reveals-what-attracts-immune-cells-to-tumors-and-what-keeps-them-away

AI tool reveals what attracts immune cells to tumors and what keeps them away

4+ hour, 49+ min ago   (456+ words) Posted by cfelixcpa | Oct 14, 2026 | SF STAT! | 0 | October 13, 2026 – Researchers at The University of Texas MD Anderson Cancer Center and collaborating institutions in Texas developed an artificial intelligence (AI) model that helps explain how immune cells find their way to specific locations…...


sciencedaily.com > releases > 2026 > 10 > 261013015800.htm

Scientists discover how harmful “zombie cells” hide from the immune system

5+ hour, 12+ min ago   (614+ words) Researchers led by Cedars-Sinai Health Sciences University have discovered a protein that may allow harmful aging cells to escape detection by the immune system. By helping these cells remain in the body instead of being cleared away, the protein could…...


bioengineer.org > zinc-locked-herbal-hydrogel-attacks-tumors-and-their-blood-supply-at-once

Zinc-Locked Herbal Hydrogel Attacks Tumors and Their Blood Supply at Once

2+ hour, 9+ min ago   (31+ words) Bioengineer.org News Source: Nathaniel Bowman. (October 14, 2026). Zinc-Locked Herbal Hydrogel Attacks Tumors and Their Blood Supply at Once. Scienmag....


guardonline.com > news > national > partillion-nanovials-to-support-2-5m-cirm-funded-study-of-car-t-cell-potency > article_c4be5c47-69ef-5c26-b2f7-5f4fb688b472.html

Partillion Nanovials to Support $2.5M CIRM-Funded Study of CAR T Cell Potency

6+ hour, 4+ min ago   (206+ words) USC-led research will combine high-dimensional flow cytometry with Nanovial-based Cell-Cell-seq to study how individual CAR T cells respond when they encounter their targets LOS ANGELES, CA / ACCESS Newswire / October 14, 2026 / Partillion Bioscience today announced that its Nanovial technology will be used…...


sana.sy > en > health > 2350706

MIT develops nanoparticle technology to target cancer and autoimmune diseases

7+ hour, 11+ min ago   (51+ words) سانا Washington, Oct. 14 (SANA) Researchers at the Massachusetts Institute of Technology (MIT) have developed a technology that uses tiny nanoparticles to redirect immune cells toward disease-causing cells, potentially paving the way for new treatments for certain cancers and autoimmune diseases....


bioengineer.org > spirulina-pigment-dismantles-a-key-shield-that-blocks-breast-cancer-drug-response

Spirulina pigment dismantles a key shield that blocks breast cancer drug response

6+ hour, 10+ min ago   (45+ words) A new cell study shows that C-phycocyanin can strip away Mcl-1-driven resistance and make the BH3-mimetic ABT-737 far more lethal to triple-negative breast cancer cells. News Source: Nathaniel Bowman. (October 14, 2026). Spirulina pigment dismantles a key shield that blocks breast cancer…...